Gallo, Linda A.
Ward, Micheal S.
Fotheringham, Amelia K.
Zhuang, Aowen
Borg, Danielle J.
Flemming, Nicole B.
Harvie, Ben M.
Kinneally, Toni L.
Yeh, Shang-Ming
McCarthy, Domenica A.
Koepsell, Hermann
Vallon, Volker
Pollock, Carol
Panchapakesan, Usha
Forbes, Josephine M.
Article History
Received: 20 January 2016
Accepted: 3 May 2016
First Online: 26 May 2016
Change Date: 7 July 2016
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Competing interests
: V.V. serves as a consultant for Boehringer-Ingelheim, Intarcia Therapeutics, and Janssen Pharmaceutical. C.P. serves on Advisory Boards for Boehringer-Ingelheim, Janssen Cilag, Merck Sharp and Dohme, Astra Zeneca (and receives speakers’ fees), and sits on Steering committees for Janssen Cilag and Baxter HealthCare.